Vita Coco
COCO Nasdaq Soft Drinks & Non-alcoholic Beverages Financials FY2019βFY2025
Vita Coco's revenue rose 18.2% to $610 million in fiscal 2025. Its operating margin was 13.5%, down from 14.3% a year earlier. Free cash flow was $39 million, down 6.9%. It paid out $11 million in dividends and buybacks, 29% of free cash flow. The diluted share count rose 1.1%.
What Vita Coco does
No business description yet.
- Legal name
- The Vita Coco Company, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001482981-26-000022
0001482981
Revenue and margins
Vita Coco had $610M of revenue in fiscal 2025, up 18.2% on the year before.
Net income and earnings per share
From fiscal 2019 to 2025, diluted EPS grew 39.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $39.0M in fiscal 2025, 6.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Vita Coco returned $11.3M to shareholders in fiscal 2025, 29% of free cash flow. The diluted share count rose 1.2%.
Value Vita Coco yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $197M and divides by 60.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 28.4x Β· peers 21.4x Β· sector 24.2x.
Balance sheet
Cash, debt and the ratios that show how comfortably Vita Coco can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $28.7M | $19.6M | $133M | $165M | $197M |
| Debt incl. finance leases | $0.1M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net debt / EBITDA | β1.1x | β4.0x | β2.3x | β2.2x | β2.4x |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 68.3x | 11.8x | 1,822.4x | β | β |
| Current ratio | 2.3x | 3.2x | 3.2x | 3.3x | 3.6x |
| Quick ratio | 1.3x | 1.7x | 2.6x | 2.5x | 2.7x |
| Total assets | $198M | $198M | $286M | $362M | $461M |
| Total liabilities | $74.3M | $56.7M | $83.2M | $104M | $130M |
| Shareholders' equity | $123M | $141M | $202M | $259M | $332M |
| Net debt (β = net cash) | β$28.6M | β$19.6M | β$133M | β$165M | β$197M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$39.8M
5 insiders
Of sales under plans
100%
$39.8M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | Kenneth SadowskyDirector | Sold plan | 3,900 | $82.92 | $0.3M | Form 4 |
| Jun 12, 2026 | Ira LiranDirector | Sold plan | 148,074 | $80.31 | $11.9M | Form 4 |
| Jun 11, 2026 | Ira LiranDirector | Sold plan | 191,926 | $79.14 | $15.2M | Form 4 |
| Jun 11, 2026 | Jonathan BurthChief Operating Officer | Sold plan | 30,000 | $80.00 | $2.4M | Form 4 |
| Jun 1, 2026 | Es Charles vanChief Commercial Officer | Sold plan | 8,045 | $75.05 | $0.6M | Form 4 |
| May 20, 2026 | Kenneth SadowskyDirector | Sold plan | 3,900 | $77.48 | $0.3M | Form 4 |
| May 12, 2026 | Jonathan BurthChief Operating Officer | Sold plan | 30,000 | $75.00 | $2.3M | Form 4 |
| May 8, 2026 | Es Charles vanChief Commercial Officer | Sold plan | 8,561 | $70.00 | $0.6M | Form 4 |
| May 8, 2026 | Jonathan BurthChief Operating Officer | Sold plan | 20,000 | $70.00 | $1.4M | Form 4 |
| May 1, 2026 | Es Charles vanChief Commercial Officer | Sold plan | 2,000 | $66.87 | $0.1M | Form 4 |
| Apr 30, 2026 | Jonathan BurthChief Operating Officer | Sold plan | 20,000 | $67.50 | $1.4M | Form 4 |
| Apr 30, 2026 | Michael KirbanExecutive Chairman, Director | Sold plan | 50,000 | $68.00 | $3.4M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 7 / 9 | 5 / 9 | 5 / 9 |
| Accruals ratio | β25.0% | 4.0% | 5.9% |
| Altman Z'' | 9.17 | 9.71 | 9.84 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Vita Coco COCO | $3.4B | 18.2% | 13.5% | 6.4% | 55.3% | 28.4x | 5 | |
| National Beverage FIZZ | $3.4B | β1.7% | 19.5% | 13.2% | 65.5% | 19.4x | 7 | Compare β |
| Celsius CELH | $7.3B | 85.5% | 5.6% | 12.9% | 25.1% | 123.8x | 5 | Compare β |
| Coca-Cola Consolidated COKE | β | 4.8% | 13.2% | 8.6% | 39.7% | β | β | Compare β |
| Monster Beverage MNST | $45.7B | 10.7% | 29.2% | 23.7% | 36.1% | 21.4x | 9 | Compare β |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $284M | $311M | $380M | $428M | $494M | $516M | $610M |
| Gross profit | $93.0M | $105M | $113M | $103M | $181M | $199M | $223M |
| Research and development | $0.6M | $0.3M | $0.5M | $0.5M | $0.4M | $0.4M | $0.4M |
| Operating income | $13.4M | $46.9M | $24.6M | $3.1M | $56.5M | $73.8M | $82.5M |
| Interest expense | $1.2M | $0.8M | $0.4M | $0.3M | $0.0M | $0.0M | $0.0M |
| Pretax income | $11.4M | $43.6M | $24.2M | $10.8M | $57.9M | $70.8M | $93.0M |
| Income tax | $2.0M | $10.9M | $5.2M | $3.0M | $11.3M | $14.8M | $21.7M |
| Net income | $9.4M | $32.7M | $19.0M | $7.8M | $46.6M | $56.0M | $71.3M |
| Diluted EPS | $0.16 | $0.56 | $0.35 | $0.14 | $0.79 | $0.94 | $1.19 |
| Diluted shares | 0.06B | 0.06B | 0.05B | 0.06B | 0.06B | 0.06B | 0.06B |
| Cash flow | |||||||
| Cash from operations | $21.8M | $33.3M | β$16.2M | β$10.9M | $107M | $42.9M | $47.2M |
| Capital expenditure | $1.0M | $0.4M | $0.6M | $1.0M | $0.6M | $1.0M | $8.1M |
| Free cash flow | $20.8M | $32.9M | β$16.7M | β$11.9M | $107M | $41.9M | $39.0M |
| Depreciation and amortization | $2.1M | $2.1M | $2.1M | $1.9M | $0.7M | $0.7M | $1.1M |
| Stock-based compensation | $2.2M | $1.5M | $3.4M | $7.4M | $9.1M | $8.9M | $10.8M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $6.9M | $50.0M | $0.0M | $0.8M | $12.0M | $11.3M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $0.0M | $6.9M | $50.0M | $0.0M | $0.8M | $12.0M | $11.3M |
| Balance sheet | |||||||
| Cash and short-term investments | $36.7M | $72.2M | $28.7M | $19.6M | $133M | $165M | $197M |
| Total debt | β | $0.1M | $0.1M | $0.0M | $0.0M | $0.0M | $0.0M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | β | $159M | $173M | $175M | $263M | $341M | $421M |
| Current liabilities | β | $55.7M | $74.0M | $54.3M | $82.6M | $103M | $116M |
| Inventory | $0.0M | $32.0M | $75.4M | $84.1M | $50.8M | $83.6M | $112M |
| Property and equipment, net | β | $2.9M | $2.5M | $2.1M | $2.1M | $2.4M | $9.3M |
| Total assets | β | $184M | $198M | $198M | $286M | $362M | $461M |
| Total liabilities | β | $81.6M | $74.3M | $56.7M | $83.2M | $104M | $130M |
| Shareholders' equity | $73.8M | $102M | $123M | $141M | $202M | $259M | $332M |
| Margins | |||||||
| Gross margin | 32.8% | 33.8% | 29.8% | 24.2% | 36.6% | 38.5% | 36.5% |
| Operating margin | 4.7% | 15.1% | 6.5% | 0.7% | 11.4% | 14.3% | 13.5% |
| EBITDA margin | 5.4% | 15.8% | 7.0% | 1.2% | 11.6% | 14.5% | 13.7% |
| Net margin | 3.3% | 10.5% | 5.0% | 1.8% | 9.5% | 10.8% | 11.7% |
| FCF margin | 7.3% | 10.6% | β4.4% | β2.8% | 21.6% | 8.1% | 6.4% |
| Returns | |||||||
| Return on capital | β | β | 30.9% | 2.0% | 47.5% | 71.1% | 55.3% |
| Return on capital employed | β | β | 19.5% | 2.3% | 32.6% | 31.9% | 27.3% |
| Return on equity | β | β | 16.9% | 5.9% | 27.2% | 24.3% | 24.2% |
| Return on assets | β | β | 10.0% | 4.0% | 19.3% | 17.3% | 17.3% |
| Growth | |||||||
| Revenue growth | β | 9.4% | 22.2% | 12.7% | 15.4% | 4.5% | 18.2% |
| Net income growth | β | 246.8% | β41.8% | β58.9% | 496.7% | 20.0% | 27.5% |
| EPS growth | β | 250.0% | β37.5% | β60.0% | 464.3% | 19.0% | 26.6% |
| FCF growth | β | 58.7% | β150.8% | β | β | β60.7% | β6.9% |
| Share count change | β | 2.6% | β7.6% | 3.6% | 4.7% | 0.9% | 1.2% |
| Financial health | |||||||
| Net debt / EBITDA | β | β1.5x | β1.1x | β4.0x | β2.3x | β2.2x | β2.4x |
| Debt / equity | β | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 11.5x | 59.2x | 68.3x | 11.8x | 1,822.4x | β | β |
| Current ratio | β | 2.9x | 2.3x | 3.2x | 3.2x | 3.3x | 3.6x |
| Quick ratio | β | 2.3x | 1.3x | 1.7x | 2.6x | 2.5x | 2.7x |
| Capital allocation | |||||||
| Capex / revenue | 0.4% | 0.1% | 0.2% | 0.2% | 0.1% | 0.2% | 1.3% |
| Stock comp / revenue | 0.8% | 0.5% | 0.9% | 1.7% | 1.9% | 1.7% | 1.8% |
| Payouts / FCF | 0.2% | 21.1% | β | β | 0.7% | 28.7% | 28.9% |
| Quality scores | |||||||
| Piotroski F-score | β | β | β | 4.0 | 7.0 | 5.0 | 5.0 |
| Altman Z'' | β | 7.2 | 6.7 | 7.6 | 9.2 | 9.7 | 9.8 |
| Accruals ratio | β | β | 18.5% | 9.5% | β25.0% | 4.0% | 5.9% |
Source: SEC EDGAR XBRL filings (CIK 0001482981). Data updated October 22, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.